At the news
? NEUTRALIMPACT 3/10 CLUSTER filed Aug 11, 2026 at 16:00 ET
Multiple C-suite and EVP insiders at iRhythm sold a total of ~$1.55M in stock over a one-week window, including the Chief Medical Officer, Chief Communications & Product Officer, and Chief Risk Officer. The selling follows a cluster of non-cash stock grants on August 7, suggesting the sales are primarily liquidity-driven to cover tax obligations or diversify concentrated positions, rather than a bearish signal on fundamentals. The total value represents ~0.04% of the $4.1B market cap, well below the 0.1% materiality threshold, making this a routine insider transaction cluster with no actionable trading signal.
- Three C-suite officers (Chief Medical/Science Officer, Chief Communications & Product Officer, Chief Risk Officer) sold shares totaling ~$2.44M in the cluster window.
- The largest sale was by Minang Turakhia (Chief Medical/Science Officer) for ~$884K on August 10.
- All three selling officers received non-cash stock grants on August 7 (13,589, 9,706, and 13,589 shares respectively), indicating the sales are likely for tax withholding or diversification.
- Total open-market sales of ~$1.55M represent ~0.04% of iRhythm's $4.1B market cap, well below the 0.1% materiality threshold for insider clusters.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access